Genetic Study of Complex Diseases in the Post-GWAS Era

Journal of Genetics and Genomics

Volumn 42, Issue 3, 2015, Pages 87-98

  Huang, Qingyang ^a  

^a CENTRAL CHINA NORMAL UNIVERSITY   (China)

Author keywords

Complex diseases; Genome wide association study; Network biology; SNP; Systems genetics

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; LONG UNTRANSLATED RNA; MICRORNA; TRANSCRIPTION FACTOR; UNTRANSLATED RNA;

ALLELE; ALZHEIMER DISEASE; ASTHMA; BIPOLAR DISORDER; BREAST CANCER; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; COMPLEX DISEASE; DISEASE PREDISPOSITION; DNA METHYLATION; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; KIDNEY CANCER; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; NONHUMAN; OVARY CANCER; PHYSICAL DISEASE BY ETIOLOGY AND PATHOGENESIS; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE TRAIT LOCUS; REVIEW; RNA SPLICING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; GENE REGULATORY NETWORK; GENETIC PREDISPOSITION; GENETICS; METABOLISM; PROCEDURES;

ANIMALS; DNA METHYLATION; GENE REGULATORY NETWORKS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA SPLICING; RNA, UNTRANSLATED; TRANSCRIPTION FACTORS;

EID: 84933671995     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2015.02.001     Document Type: Review

References (92)

1. Ahmadiyeh N., Pomerantz M.M., Grisanzio C., Herman P., Jia L., Almendro V., He H.H., Brown M., Liu X.S., Davis M., Caswell J.L., Beckwith C.A., Hills A., Macconaill L., Coetzee G.A., Regan M.M., Freedman M.L. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC. Proc. Natl. Acad. Sci. USA 2010, 107:9742-9746.
2. Aran D., Sabato S., Hellman A. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes. Genome Biol. 2013, 14:R21.
3. Bauer D.E., Kamran S.C., Lessard S., Xu J., Fujiwara Y., Lin C., Shao Z., Canver M.C., Smith E.C., Pinello L., Sabo P.J., Vierstra J., Voit R.A., Yuan G.C., Porteus M.H., Stamatoyannopoulo J.A., Lettre G., Orkin S.H. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 2013, 342:253-257.
4. Bell C.G., Finer S., Lindgren C.M., Wilson G.A., Rakyan V.K., Teschendorff A.E., Akan P., Stupka E., Down T.A., Prokopenko I., Morison I.M., Mill J., Pidsley R., International Type 2 Diabetes 1q Consortium, Deloukas P., Frayling T.M., Hattersley A.T., McCarthy M.I., Beck S., Hitman G.A. Integrated genetic and epigenetic analysis identifies haplotype-specific methylation in the FTO type 2 diabetes and obesity susceptibility locus. PLoS One 2010, 5:e14040.
5. Bergholdt R., Brorsson C., Palleja A., Berchtold L.A., Floyel T., Bang-Berthelsen C.H., Frederiksen K.S., Jensen L.J., Storling J., Pociot F. Identification of novel type 1 diabetes candidate genes by integrating genome-wide association data, protein-protein interactions, and human pancreatic islet gene expression. Diabetes 2012, 61:954-962.
6. Bojesen S.E., Pooley K.A., Johnatty S.E., Beesley J., Michailidou K., Tyrer J.P., Edwards S.L., Pickett H.A., Shen H.C., Smart C.E., Hillman K.M., Mai P.L., Lawrenson K., Stutz M.D., Lu Y., Karevan R., Woods N., Johnston R.L., French J.D., Chen X., Weischer M., Nielsen S.F., Maranian M.J., Ghoussaini M., Ahmed S., Baynes C., Bolla M.K., Wang Q., Dennis J., McGuffog L., Barrowdale D., Lee A., Healey S., Lush M., Tessier D.C., Vincent D., Bacot F., Australian Cancer Study, Australian Ovarian Cancer Study, Kathleen Cuningham Foundation Consortium for Research into Familial BreastCancer (kConFab), Gene Environment Interaction and Breast Cancer (GENICA), Swedish Breast Cancer Study(SWE-BRCA), Hereditary Breastand Ovarian Cancer Research Group Netherlands (HEBON), Epidemiological study of BRCA1 & BRCA2 Mutation Carriers (EMBRACE), Genetic Modifiers of Cancer Risk in BRCA1/2 Mutation Carriers (GEMO), Vergote I., Lambrechts S., Despierre E., Risch H.A., González-Neira A., Rossing M.A., Pita G., Doherty J.A., Alvarez N., Larson M.C., Fridley B.L., Schoof N., Chang-Claude J., Cicek M.S., Peto J., Kalli K.R., Broeks A., Armasu S.M., Schmidt M.K., Braaf L.M., Winterhoff B., Nevanlinna H., Konecny G.E., Lambrechts D., Rogmann L., Guénel P., Teoman A., Milne R.L., Garcia J.J., Cox A., Shridhar V., Burwinkel B., Marme F., Hein R., Sawyer E.J., Haiman C.A., Wang-Gohrke S., Andrulis I.L., Moysich K.B., Hopper J.L., Odunsi K., Lindblom A., Giles G.G., Brenner H., Simard J., Lurie G., Fasching P.A., Carney M.E., Radice P., Wilkens L.R., Swerdlow A., Goodman M.T., Brauch H., Garcia-Closas M., Hillemanns P., Winqvist R., Dürst M., Devilee P., Runnebaum I., Jakubowska A., Lubinski J., et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat. Genet. 2013, 45:371-384.
7. Bruno A.E., Li L., Kalabus J.L., Pan Y., Yu A., Hu Z. miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3' UTRs of human genes. BMC Genomics 2012, 13:44.
8. Burkhardt R., Kenny E.E., Lowe J.K., Birkeland A., Josowitz R., Noel M., Salit J., Maller J.B., Pe'er I., Daly M.J., Altshuler D., Stoffel M., Friedman J.M., Breslow J.L. Common SNPs in HMGCR in Micronesians and Caucasians associated with LDL-Cholesterol levels affect alternative splicing of exon13. Arterioscler. Thromb. Vasc. Biol. 2008, 28:2078-2084.
9. Caussy C., Charrière S., Marçais C., Di Filippo M., Sassolas A., Delay M., Euthine V., Jalabert A., Lefai E., Rome S., Moulin P. An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am. J. Hum. Genet. 2014, 94:129-134.
10. Civelek M., Lusis A.J. Systems genetics approaches to understand complex traits. Nat. Rev. Genet. 2014, 15:34-48.
11. Claussnitzer M., Dankel S.N., Klocke B., Grallert H., Glunk V., Berulava T., Lee H., Oskolkov N., Fadista J., Ehlers K., Wahl S., Hoffmann C., Qian K., Rönn T., Riess H., Müller-Nurasyid M., Bretschneider N., Schroeder T., Skurk T., Horsthemke B., DIAGRAM+Consortium, Spieler D., Klingenspor M., Seifert M., Kern M.J., Mejhert N., Dahlman I., Hansson O., Hauck S.M., Blüher M., Arner P., Groop L., Illig T., Suhre K., Hsu Y.H., Mellgren G., Hauner H., Laumen H. Leveraging cross-species transcription factor binding site patterns: from diabetes risk loci to disease mechanisms. Cell 2014, 156:343-358.
12. Cowper-Sal lari R., Zhang X., Wright J.B., Bailey S.D., Cole M.D., Eeckhoute J., Moore J.H., Lupien M. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression. Nat. Genet. 2012, 44:1191-1198.
13. Dayeh T.A., Olsson A.H., Volkov P., Almgren P., Rönn T., Ling C. Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia 2013, 56:1036-1046.
14. De Gobbi M., Viprakasit V., Hughes J.R., Fisher C., Buckle V.J., Ayyub H., Gibbons R.J., Vernimmen D., Yoshinaga Y., de Jong P., Cheng J.F., Rubin E.M., Wood W.G., Bowden D., Higgs D.R. A regulatory SNP causes a human genetic disease by creating a new transcriptional promoter. Science 2006, 312:1215-1217.
15. Deveci M., Catalyürek U.V., Toland A.E. mrSNP: software to detect SNP effects on microRNA binding. BMC Bioinformatics 2014, 15:73.
16. Edwards S.L., Beesley J., French J.D., Dunning A.M. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 2013, 93:779-797.
17. Bernstein B.E., Birney E., Dunham I., Green E.D., Gunter C., Snyder M. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. ENCODE Project Consortium.
18. Farber C.R., Bennett B.J., Orozco L., Zou W., Lira A., Kostem E., Kang H.M., Furlotte N., Berberyan A., Ghazalpour A., Suwanwela J., Drake T.A., Eskin E., Wang Q.T., Teitelbaum S.L., Lusis A.J. Mouse genome-wide association and systems genetics identify Asxl2 as a regulator of bone mineral density and osteoclastogenesis. PLoS Genet. 2011, 7:e1002038.
19. Fogarty M.P., Cannon M.E., Vadlamudi S., Gaulton K.J., Mohlke K.L. Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genet. 2014, 10:e1004633.
20. French J.D., Ghoussaini M., Edwards S.L., Meyer K.B., Michailidou K., Ahmed S., Khan S., Maranian M.J., O'Reilly M., Hillman K.M., Betts J.A., Carroll T., Bailey P.J., Dicks E., Beesley J., Tyrer J., Maia A.T., Beck A., Knoblauch N.W., Chen C., Kraft P., Barnes D., González-Neira A., Alonso M.R., Herrero D., Tessier D.C., Vincent D., Bacot F., Luccarini C., Baynes C., Conroy D., Dennis J., Bolla M.K., Wang Q., Hopper J.L., Southey M.C., Schmidt M.K., Broeks A., Verhoef S., Cornelissen S., Muir K., Lophatananon A., Stewart-Brown S., Siriwanarangsan P., Fasching P.A., Loehberg C.R., Ekici A.B., Beckmann M.W., Peto J., dos Santos Silva I., Johnson N., Aitken Z., Sawyer E.J., Tomlinson I., Kerin M.J., Miller N., Marme F., Schneeweiss A., Sohn C., Burwinkel B., Guénel P., Truong T., Laurent-Puig P., Menegaux F., Bojesen S.E., Nordestgaard B.G., Nielsen S.F., Flyger H., Milne R.L., Zamora M.P., Arias Perez J.I., Benitez J., Anton-Culver H., Brenner H., Müller H., Arndt V., Stegmaier C., Meindl A., Lichtner P., Schmutzler R.K., Engel C., Brauch H., Hamann U., Justenhoven C., GENICA Network, Aaltonen K., Heikkilä P., Aittomäki K., Blomqvist C., Matsuo K., Ito H., Iwata H., Sueta A., Bogdanova N.V., Antonenkova N.N., Dörk T., Lindblom A., Margolin S., Mannermaa A., Kataja V., Kosma V.M., Hartikainen J.M., kConFab Investigators, Wu A.H., Tseng C.C., Van Den Berg D., Stram D.O., Lambrechts D., Peeters S., Smeets A., Floris G., Chang-Claude J., Rudolph A., Nickels S., Flesch-Janys D., Radice P., Peterlongo P., Bonanni B., Sardella D., Couch F.J., Wang X., Pankratz V.S., Lee A., Giles G.G., Severi G., Baglietto L., Haiman C.A., Henderson B.E., Schumacher F., Le Marchand L., Simard J., Goldberg M.S., Labrèche F., Dumont M., Teo S.H., Yip C.H., Ng C.H., Vithana E.N., Kristensen V., Zheng W., Deming-Halverson S., Shrubsole M., Long J., Winqvist R., Pylkäs K., Jukkola-Vuorinen A., Grip M., Andrulis I.L., Knight J.A., Glendon G., Mulligan A.M., Devilee P., Seynaeve C., García-Closas M., Figueroa J., Chanock S.J., Lissowska J., Czene K., Klevebring D., Schoof N., Hooning M.J., Martens J.W., Collée J.M., Tilanus-Linthorst M., Hall P., Li J., Liu J., Humphreys K., Shu X.O., Lu W., Gao Y.T., Cai H., Cox A., Balasubramanian S.P., Blot W., Signorello L.B., Cai Q., Pharoah P.D., Healey C.S., Shah M., Pooley K.A., Kang D., Yoo K.Y., Noh D.Y., Hartman M., Miao H., Sng J.H., Sim X., Jakubowska A., Lubinski J., Jaworska-Bieniek K., Durda K., Sangrajrang S., Gaborieau V., McKay J., Toland A.E., Ambrosone C.B., Yannoukakos D., Godwin A.K., Shen C.Y., Hsiung C.N., Wu P.E., Chen S.T., Swerdlow A., Ashworth A., Orr N., Schoemaker M.J., Ponder B.A., Nevanlinna H., Brown M.A., Chenevix-Trench G., Easton D.F., Dunning A.M. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am. J. Hum. Genet. 2013, 92:489-503.
21. Furlong L.I. Human diseases through the lens of network biology. Trends Genet. 2013, 29:150-159.
22. Ghoussaini M., Edwards S.L., Michailidou K., Nord S., Cowper-Sal Lari R., Desai K., Kar S., Hillman K.M., Kaufmann S., Glubb D.M., Beesley J., Dennis J., Bolla M.K., Wang Q., Dicks E., Guo Q., Schmidt M.K., Shah M., Luben R., Brown J., Czene K., Darabi H., Eriksson M., Klevebring D., Bojesen S.E., Nordestgaard B.G., Nielsen S.F., Flyger H., Lambrechts D., Thienpont B., Neven P., Wildiers H., Broeks A., Van't Veer L.J., Th Rutgers E.J., Couch F.J., Olson J.E., Hallberg E., Vachon C., Chang-Claude J., Rudolph A., Seibold P., Flesch-Janys D., Peto J., Dos-Santos-Silva I., Gibson L., Nevanlinna H., Muranen T.A., Aittomäki K., Blomqvist C., Hall P., Li J., Liu J., Humphreys K., Kang D., Choi J.Y., Park S.K., Noh D.Y., Matsuo K., Ito H., Iwata H., Yatabe Y., Guénel P., Truong T., Menegaux F., Sanchez M., Burwinkel B., Marme F., Schneeweiss A., Sohn C., Wu A.H., Tseng C.C., Van Den Berg D., Stram D.O., Benitez J., Zamora M.P., Perez J.I., Menéndez P., Shu X.O., Lu W., Gao Y.T., Cai Q., Cox A., Cross S.S., Reed M.W., Andrulis I.L., Knight J.A., Glendon G., Tchatchou S., Sawyer E.J., Tomlinson I., Kerin M.J., Miller N., Haiman C.A., Henderson B.E., Schumacher F., Le Marchand L., Lindblom A., Margolin S., Teo S.H., Yip C.H., Lee D.S., Wong T.Y., Hooning M.J., Martens J.W., Collée J.M., van Deurzen C.H., Hopper J.L., Southey M.C., Tsimiklis H., Kapuscinski M.K., Shen C.Y., Wu P.E., Yu J.C., Chen S.T., Alnæs G.G., Borresen-Dale A.L., Giles G.G., Milne R.L., McLean C., Muir K., Lophatananon A., Stewart-Brown S., Siriwanarangsan P., Hartman M., Miao H., Buhari S.A., Teo Y.Y., Fasching P.A., Haeberle L., Ekici A.B., Beckmann M.W., Brenner H., Dieffenbach A.K., Arndt V., Stegmaier C., Swerdlow A., Ashworth A., Orr N., Schoemaker M.J., García-Closas M., Figueroa J., Chanock S.J., Lissowska J., Simard J., Goldberg M.S., Labrèche F., Dumont M., Winqvist R., Pylkäs K., Jukkola-Vuorinen A., Brauch H., Brüning T., Koto Y.D., Radice P., Peterlongo P., Bonanni B., Volorio S., Dörk T., Bogdanova N.V., Helbig S., Mannermaa A., Kataja V., Kosma V.M., Hartikainen J.M., Devilee P., Tollenaar R.A., Seynaeve C., Van Asperen C.J., Jakubowska A., Lubinski J., Jaworska-Bieniek K., Durda K., Slager S., Toland A.E., Ambrosone C.B., Yannoukakos D., Sangrajrang S., Gaborieau V., Brennan P., McKay J., Hamann U., Torres D., Zheng W., Long J., Anton-Culver H., Neuhausen S.L., Luccarini C., Baynes C., Ahmed S., Maranian M., Healey C.S., González-Neira A., Pita G., Alonso M.R., Alvarez N., Herrero D., Tessier D.C., Vincent D., Bacot F., de Santiago I., Carroll J., Caldas C., Brown M.A., Lupien M., Kristensen V.N., Pharoah P., Chenevix-Trench G., French J.D., Easton D.F., Dunning A.M. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat. Commun. 2014, 23:4999. Australian Ovarian Cancer Management Group.
23. Gong J., Tong Y., Zhang H.M., Wang K., Hu T., Shan G., Sun J., Guo A.Y. Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum. Mutat. 2012, 33:254-263.
24. Gregory A.P., Dendrou C.A., Attfield K.E., Haghikia A., Xifara D.K., Butter F., Poschmann G., Kaur G., Lambert L., Leach O.A., Prömel S., Punwani D., Felce J.H., Davis S.J., Gold R., Nielsen F.C., Siegel R.M., Mann M., Bell J.I., McVean G., Fugger L. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012, 488:508-511.
25. Harismendy O., Notani D., Song X., Rahim N.G., Tanasa B., Heintzman N., Ren B., Fu X.D., Topol E.J., Rosenfeld M.G., Frazer K.A. 9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response. Nature 2011, 470:264-268.
26. Hausser J., Zavolan M. Identification and consequences of miRNA-target interactions-beyond repression of gene expression. Nat. Rev. Genet. 2014, 15:599-612.
27. Hindorff L.A., Sethupathy P., Junkins H.A., Ramos E.M., Mehta J.P., Collins F.S., Manolio T.A. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. USA 2009, 106:9362-9367.
28. Hitchins M.P., Rapkins R.W., Kwok C.T., Srivastava S., Wong J.J., Khachigian L.M., Polly P., Goldblatt J., Ward R.L. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5'UTR. Cancer Cell 2011, 20:200-213.
29. Huan T., Zhang B., Wang Z., Joehanes R., Zhu J., Johnson A.D., Ying S., Munson P.J., Raghavachari N., Wang R., Liu P., Courchesne P., Hwang S.J., Assimes T.L., McPherson R., Samani N.J., Schunkert H., Coronary ARteryDIsease Genome wide Replication and Meta-analysis (CARDIoGRAM) Consortium, International Consortium for Blood Pressure GWAS (ICBP), Meng Q., Suver C., O'Donnell C.J., Derry J., Yang X., Levy D. A systems biology framework identifies molecular underpinnings of coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1427-1434.
30. Huang Q., Whitington T., Gao P., Lindberg J.F., Yang Y., Sun J., Väisänen M.R., Szulkin R., Annala M., Yan J., Egevad L.A., Zhang K., Lin R., Jolma A., Nykter M., Manninen A., Wiklund F., Vaarala M.H., Visakorpi T., Xu J., Taipale J., Wei G.H. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. Nat. Genet. 2014, 46:126-135.
31. Hutchinson J.N., Raj T., Fagerness J., Stahl E., Viloria F.T., Gimelbrant A., Seddon J., Daly M., Chess A., Plenge R. Allele-specific methylation occurs at genetic variants associated with complex disease. PLoS One 2014, 9:e98464.
32. Ishii N., Ozaki K., Sato H., Mizuno H., Saito S., Takahashi A., Miyamoto Y., Ikegawa S., Kamatani N., Hori M., Saito S., Nakamura Y., Tanaka T. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J. Hum. Genet. 2006, 51:1087-1099.
33. Jendrzejewski J., He H., Radomska H.S., Li W., Tomsic J., Liyanarachchi S., Davuluri R.V., Nagy R., de la Chapelle A. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc. Natl. Acad. Sci. USA 2012, 109:8646-8651.
34. Jia L., Landan G., Pomerantz M., Jaschek R., Herman P., Reich D., Yan C., Khalid O., Kantoff P., Oh W., Manak J.R., Berman B.P., Henderson B.E., Frenkel B., Haiman C.A., Freedman M., Tanay A., Coetzee G.A. Functional enhancers at the gene-poor 8q24 cancer-linked locus. PLoS Genet. 2009, 5:e1000597.
35. Kapeller J., Houghton L.A., Mönnikes H., Walstab J., Möller D., Bönisch H., Burwinkel B., Autschbach F., Funke B., Lasitschka F., Gassler N., Fischer C., Whorwell P.J., Atkinson W., Fell C., Büchne K.J., Schmidtmann M., van der Voort I., Wisser A.S., Ber T., Rappold G., Niesler B. Evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome. Hum. Mol. Genet. 2008, 17:2967-2977.
36. Kulkarni S., Savan R., Qi Y., Gao X., Yuki Y., Bass S.E., Martin M.P., Hunt P., Deeks S.G., Telenti A., Pereyra F., Goldstein D., Wolinsky S., Walker B., Young H.A., Carrington M. Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 2011, 472:495-498.
37. Kulzer J.R., Stitzel M.L., Morken M.A., Huyghe J.R., Fuchsberger C., Kuusisto J., Laakso M., Boehnke M., Collins F.S., Mohlke K.L. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell. Am. J. Hum. Genet. 2014, 94:186-197.
38. Kumar V., Westra H.J., Karjalainen J., Zhernakova D.V., Esko T., Hrdlickova B., Almeida R., Zhernakova A., Reinmaa E., Võsa U., Hofker M.H., Fehrmann R.S., Fu J., Withoff S., Metspalu A., Franke L., Wijmenga C. Human disease-associated genetic variation impacts large intergenic non-coding RNA expression. PLoS Genet. 2013, 9:e1003201.
39. Liu C., Zhang F., Li T., Lu M., Wang L., Yue W., Zhang D. MirSNP, a database of polymorphisms altering miRNA target sites, identifies miRNA-related SNPs in GWAS SNPs and eQTLs. BMC Genomics 2012, 13:661.
40. López-Bigas N., Audit B., Ouzounis C., Parra G., Guigó R. Are splicing mutations the most frequent cause of hereditary disease?. FEBS Lett. 2005, 579:1900-1903.
41. Macintyre G., Bailey J., Haviv I., Kowalczyk A. is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 2010, 26:i524-530.
42. Mäkinen V.P., Civelek M., Meng Q., Zhang B., Zhu J., Levian C., Huan T., Segrè A.V., Ghosh S., Vivar J., Nikpay M., Stewart A.F., Nelson C.P., Willenborg C., Erdmann J., Blakenberg S., O'Donnell C.J., März W., Laaksonen R., Epstein S.E., Kathiresan S., Shah S.H., Hazen S.L., Reilly M.P., Coronary ARtery DIsease Genome-Wide Replication And Meta-Analysis (CARDIoGRAM) Consortium, Lusis A.J., Samani N.J., Schunkert H., Quertermous T., McPherson R., Yang X., Assimes T.L. Integrative genomics reveals novel molecular pathways and gene networks for coronary artery disease. PLoS Genet. 2014, 10:e1004502.
43. Malik M., Simpson J.F., Parikh I., Wilfred B.R., Fardo D.W., Nelson P.T., Estus S. CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing. J. Neurosci. 2013, 33:13320-13325.
44. Matys V., Fricke E., Geffers R., Gössling E., Haubrock M., Hehl R., Hornischer K., Karas D., Kel A.E., Kel-Margoulis O.V., Kloos D.U., Land S., Lewicki-Potapov B., Michael H., Münch R., Reuter I., Rotert S., Saxel H., Scheer M., Thiele S., Wingender E. TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res. 2003, 31:374-378.
45. Maurano M.T., Humbert R., Rynes E., Thurman R.E., Haugen E., Wang H., Reynolds A.P., Sandstrom R., Qu H., Brody J., Shafer A., Neri F., Lee K., Kutyavin T., Stehling-Sun S., Johnson A.K., Canfield T.K., Giste E., Diegel M., Bates D., Hansen R.S., Neph S., Sabo P.J., Heimfeld S., Raubitschek A., Ziegler S., Cotsapas C., Sotoodehnia N., Glass I., Sunyaev S.R., Kaul R., Stamatoyannopoulos J.A. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
46. Meyer K.B., O'Reilly M., Michailidou K., Carlebur S., Edwards S.L., French J.D., Prathalingham R., Dennis J., Bolla M.K., Wang Q., de Santiago I., Hopper J.L., Tsimiklis H., Apicella C., Southey M.C., Schmidt M.K., Broeks A., Van 't Veer L.J., Hogervorst F.B., Muir K., Lophatananon A., Stewart-Brown S., Siriwanarangsan P., Fasching P.A., Lux M.P., Ekici A.B., Beckmann M.W., Peto J., Dos Santos Silva I., Fletcher O., Johnson N., Sawyer E.J., Tomlinson I., Kerin M.J., Miller N., Marme F., Schneeweiss A., Sohn C., Burwinkel B., Guénel P., Truong T., Laurent-Puig P., Menegaux F., Bojesen S.E., Nordestgaard B.G., Nielsen S.F., Flyger H., Milne R.L., Zamora M.P., Arias J.I., Benitez J., Neuhausen S., Anton-Culver H., Ziogas A., Dur C.C., Brenner H., Müller H., Arndt V., Stegmaier C., Meindl A., Schmutzler R.K., Engel C., Ditsch N., Brauch H., Brüning T., Ko Y.D., GENICA Network, Nevanlinna H., Muranen T.A., Aittomäki K., Blomqvist C., Matsuo K., Ito H., Iwata H., Yatabe Y., Dörk T., Helbig S., Bogdanova N.V., Lindblom A., Margolin S., Mannermaa A., Kataja V., Kosma V.M., Hartikainen J.M., Chenevix-Trench G., kConFab Investigators, Australian Ovarian Cancer Study Group, Wu A.H., Tseng C.C., Van Den Berg D., Stram D.O., Lambrechts D., Thienpont B., Christiaens M.R., Smeets A., Chang-Claude J., Rudolph A., Seibold P., Flesch-Janys D., Radice P., Peterlongo P., Bonanni B., Bernard L., Couch F.J., Olson J.E., Wang X., Purrington K., Giles G.G., Severi G., Baglietto L., McLean C., Haiman C.A., Henderson B.E., Schumacher F., Le Marchand L., Simard J., Goldberg M.S., Labrèche F., Dumont M., Teo S.H., Yip C.H., Phuah S.Y., Kristensen V., Grenaker Alnæs G., Børresen-Dale A.L., Zheng W., Deming-Halverson S., Shrubsole M., Long J., Winqvist R., Pylkäs K., Jukkola-Vuorinen A., Kauppila S., Andrulis I.L., Knight J.A., Glendon G., Tchatchou S., Devilee P., Tollenaar R.A., Seynaeve C.M., García-Closas M., Figueroa J., Chanock S.J., Lissowska J., Czene K., Darabi H., Eriksson K., Hooning M.J., Martens J.W., van den Ouweland A.M., van Deurzen C.H., Hall P., Li J., Liu J., Humphreys K., Shu X.O., Lu W., Gao Y.T., Cai H., Cox A., Reed M.W., Blot W., Signorello L.B., Cai Q., Pharoah P.D., Ghoussaini M., Harrington P., Tyrer J., Kang D., Choi J.Y., Park S.K., Noh D.Y., Hartman M., Hui M., Lim W.Y., Buhari S.A., Hamann U., Försti A., Rüdiger T., Ulmer H.U., Jakubowska A., Lubinski J., Jaworska K., Durda K., Sangrajrang S., Gaborieau V., Brennan P., McKay J., Vachon C., Slager S., Fostira F., Pilarski R., Shen C.Y., Hsiung C.N., Wu P.E., Hou M.F., Swerdlow A., Ashworth A., Orr N., Schoemaker M.J., Ponder B.A., Dunning A.M., Easton D.F. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1and E2F1. Am. J. Hum. Genet. 2013, 93:1046-1060.
47. Meyer K.B., Maia A.T., O'Reilly M., Teschendorff A.E., Chin S.F., Caldas C., Ponder B.A. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol. 2008, 6:e108.
48. Miller C.L., Haas U., Diaz R., Leeper N.J., Kundu R.K., Patlolla B., Assimes T.L., Kaiser F.J., Perisic L., Hedin U., Maegdefessel L., Schunkert H., Erdmann J., Quertermous T., Sczakiel G. Coronary heart disease-associated variation in TCF21 disrupts a miR-224 binding site and miRNA-mediated regulation. PLoS Genet. 2014, 10:e1004263.
49. Musunuru K., Strong A., Frank-Kamenetsky M., Lee N.E., Ahfeldt T., Sachs K.V., Li X., Li H., Kuperwasser N., Ruda V.M., Pirruccello J.P., Muchmore B., Prokunina-Olsson L., Hall J.L., Schadt E.E., Morales C.R., Lund-Katz S., Phillips M.C., Wong J., Cantley W., Racie T., Ejebe K.G., Orho-Melander M., Melander O., Koteliansky V., Fitzgerald K., Krauss R.M., Cowan C.A., Kathiresan S., Rader D.J. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-719.
50. Nakata K., Lipska B.K., Hyde T.M., Ye T., Newburn E.N., Morita Y., Vakkalanka R., Barenboim M., Sei Y., Weinberger D.R., Kleinman J.E. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proc. Natl. Acad. Sci. USA 2009, 106:15873-15878.
51. Nguyen H.H., Takata R., Akamatsu S., Shigemizu D., Tsunoda T., Furihata M., Takahashi A., Kubo M., Kamatani N., Ogawa O., Fujioka T., Nakamura Y., Nakagawa H. IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility. Hum. Mol. Genet. 2012, 21:2076-2085.
52. Nicolae D.L., Gamazon E., Zhang W., Duan S., Dolan M.E., Cox N.J. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 2010, 6:e1000888.
53. Nicoloso M.S., Sun H., Spizzo R., Kim H., Wickramasinghe P., Shimizu M., Wojcik S.E., Ferdin J., Kunej T., Xiao L., Manoukian S., Secreto G., Ravagnani F., Wang X., Radice P., Croce C.M., Davuluri R.V., Calin G.A. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010, 70:2789-2798.
54. Ning S., Zhao Z., Ye J., Wang P., Zhi H., Li R., Wang T., Li X. LincSNP: a database of linking disease-associated SNPs to human large intergenic non-coding RNAs. BMC Bioinformatics 2014, 15:152.
55. Paraboschi E.M., Rimoldi V., Soldà G., Tabaglio T., Dall'Osso C., Saba E., Vigliano M., Salviati A., Leone M., Benedetti M.D., Fornasari D., Saarela J., De Jager P.L., Patsopoulos N.A., D'Alfonso S., Gemmati D., Duga S., Asselta R. Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Hum. Mol. Genet. 2014, 20:6746-6761.
56. Pasmant E., Sabbagh A., Vidaud M., Bièche I. ANRIL, a long, noncoding RNA, is an unexpected major hotspot in GWAS. FASEB J. 2011, 25:444-448.
57. Pittman A.M., Naranjo S., Jalava S.E., Twiss P., Ma Y., Olver B., Lloyd A., Vijayakrishnan J., Qureshi M., Broderick P., van Wezel T., Morreau H., Tuupanen S., Aaltonen L.A., Alonso M.E., Manzanares M., Gavilán A., Visakorpi T., Gómez-Skarmeta J.L., Houlston R.S. Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H. PLoS Genet. 2010, 6:e1001126.
58. Pomerantz M.M., Ahmadiyeh N., Jia L., Herman P., Verzi M.P., Doddapaneni H., Beckwith C.A., Chan J.A., Hills A., Davis M., Yao K., Kehoe S.M., Lenz H.J., Haiman C.A., Yan C., Henderson B.E., Frenkel B., Barretina J., Bass A., Tabernero J., Baselga J., Regan M.M., Manak J.R., Shivdasani R., Coetzee G.A., Freedman M.L. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat. Genet. 2009, 41:882-884.
59. Praetorius C., Grill C., Stacey S.N., Metcalf A.M., Gorkin D.U., Robinson K.C., Van Otterloo E., Kim R.S., Bergsteinsdottir K., Ogmundsdottir M.H., Magnusdottir E., Mishra P.J., Davis S.R., Guo T., Zaidi M.R., Helgason A.S., Sigurdsson M.I., Meltzer P.S., Merlino G., Petit V., Larue L., Loftus S.K., Adams D.R., Sobhiafshar U., Emre N.C., Pavan W.J., Cornell R., Smith A.G., McCallion A.S., Fisher D.E., Stefansson K., Sturm R.A., Steingrimsson E. A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell 2013, 155:1022-1033.
60. Rademakers R., Eriksen J.L., Baker M., Robinson T., Ahmed Z., Lincoln S.J., Finch N., Rutherford N.J., Crook R.J., Josephs K.A., Boeve B.F., Knopman D.S., Petersen R.C., Parisi J.E., Caselli R.J., Wszolek Z.K., Uitti R.J., Feldman H., Hutton M.L., Mackenzie I.R., Graff-Radford N.R., Dickson D.W. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum. Mol. Genet. 2008, 17:3631-3642.
61. Raval A., Tanner S.M., Byrd J.C., Angerman E.B., Perko J.D., Chen S.S., Hackanson B., Grever M.R., Lucas D.M., Matkovic J.J., Lin T.S., Kipps T.J., Murray F., Weisenburger D., Sanger W., Lynch J., Watson P., Jansen M., Yoshinaga Y., Rosenquist R., de Jong P.J., Coggill P., Beck S., Lynch H., de la Chapelle A., Plass C. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007, 129:879-890.
62. Reynard L.N., Bui C., Canty-Laird E.G., Young D.A., Loughlin J. Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. Hum. Mol. Genet. 2011, 20:3450-3460.
63. Reynard L.N., Bui C., Syddall C.M., Loughlin J. CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383. Hum. Genet. 2014, 133:1059-1073.
64. Richardson K., Louie-Gao Q., Arnett D.K., Parnell L.D., Lai C.Q., Davalos A., Fox C.S., Demissie S., Cupples L.A., Fernandez-Hernando C., Ordovas J.M. The PLIN4 variant rs8887 modulates obesity related phenotypes in humans through creation of a novel miR-522 seed site. PLoS One 2011, 6:e17944.
65. Richardson K., Nettleton J.A., Rotllan N., Tanaka T., Smith C.E., Lai C.Q., Parnell L.D., Lee Y.C., Lahti J., Lemaitre R.N., Manichaikul A., Keller M., Mikkilä V., Ngwa J., van Rooij F.J., Ballentyne C.M., Borecki I.B., Cupples L.A., Garcia M., Hofman A., Ferrucci L., Mozaffarian D., Perälä M.M., Raitakari O., Tracy R.P., Arnett D.K., Bandinelli S., Boerwinkle E., Eriksson J.G., Franco O.H., Kähönen M., Nalls M., Siscovick D.S., Houston D.K., Psaty B.M., Viikari J., Witteman J.C., Goodarzi M.O., Lehtimäki T., Liu Y., Zillikens M.C., Chen Y.D., Uitterlinden A.G., Rotter J.I., Fernandez-Hernando C., Ordovas J.M. Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am. J. Hum. Genet. 2013, 92:5-14.
66. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6:597-610.
67. Sandelin A., Alkema W., Engstrom P., Wasserman W.W., Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004, 32:D91-D94.
68. Schödel J., Bardella C., Sciesielski L.K., Brown J.M., Pugh C.W., Buckle V., Tomlinson I.P., Ratcliffe P.J., Mole D.R. Common genetic variants at the 11q13.3 renal cancer susceptibility locus influence binding of HIF to an enhancer of cyclin D1 expression. Nat. Genet. 2012, 44:420-425.
69. Seo S., Takayama K., Uno K., Ohi K., Hashimoto R., Nishizawa D., Ikeda K., Ozaki N., Nabeshima T., Miyamoto Y., Nitta A. Functional analysis of deep intronic SNP rs13438494 in intron 24 of PCLO gene. PLoS One 2013, 8:e76960.
70. Shen H., Fridley B.L., Song H., Lawrenson K., Cunningham J.M., Ramus S.J., Cicek M.S., Tyrer J., Stram D., Larson M.C., Köbel M., PRACTICAL Consortium, Ziogas A., Zheng W., Yang H.P., Wu A.H., Wozniak E.L., Woo Y.L., Winterhoff B., Wik E., Whittemore A.S., Wentzensen N., Weber R.P., Vitonis A.F., Vincent D., Vierkant R.A., Vergote I., Van Den Berg D., Van Altena A.M., Tworoger S.S., Thompson P.J., Tessier D.C., Terry K.L., Teo S.H., Templeman C., Stram D.O., Southey M.C., Sieh W., Siddiqui N., Shvetsov Y.B., Shu X.O., Shridhar V., Wang-Gohrke S., Severi G., Schwaab I., Salvesen H.B., Rzepecka I.K., Runnebaum I.B., Rossing M.A., Rodriguez-Rodriguez L., Risch H.A., Renner S.P., Poole E.M., Pike M.C., Phelan C.M., Pelttari L.M., Pejovic T., Paul J., Orlow I., Omar S.Z., Olson S.H., Odunsi K., Nickels S., Nevanlinna H., Ness R.B., Narod S.A., Nakanishi T., Moysich K.B., Monteiro A.N., Moes-Sosnowska J., Modugno F., Menon U., McLaughlin J.R., McGuire V., Matsuo K., Adenan N.A., Massuger L.F., Lurie G., Lundvall L., Lubiński J., Lissowska J., Levine D.A., Leminen A., Lee A.W., Le N.D., Lambrechts S., Lambrechts D., Kupryjanczyk J., Krakstad C., Konecny G.E., Kjaer S.K., Kiemeney L.A., Kelemen L.E., Keeney G.L., Karlan B.Y., Karevan R., Kalli K.R., Kajiyama H., Ji B.T., Jensen A., Jakubowska A., Iversen E., Hosono S., Høgdall C.K., Høgdall E., Hoatlin M., Hillemanns P., Heitz F., Hein R., Harter P., Halle M.K., Hall P., Gronwald J., Gore M., Goodman M.T., Giles G.G., Gentry-Maharaj A., Garcia-Closas M., Flanagan J.M., Fasching P.A., Ekici A.B., Edwards R., Eccles D., Easton D.F., Dürst M., du Bois A., Dörk T., Doherty J.A., Despierre E., Dansonka-Mieszkowska A., Cybulski C., Cramer D.W., Cook L.S., Chen X., Charbonneau B., Chang-Claude J., Campbell I., Butzow R., Bunker C.H., Brueggmann D., Brown R., Brooks-Wilson A., Brinton L.A., Bogdanova N., Block M.S., Benjamin E., Beesley J., Beckmann M.W., Bandera E.V., Baglietto L., Bacot F., Armasu S.M., Antonenkova N., Anton-Culver H., Aben K.K., Liang D., Wu X., Lu K., Hildebrandt M.A., Australian Ovarian Cancer Study Group, Australian Cancer Study, Schildkraut J.M., Sellers T.A., Huntsman D., Berchuck A., Chenevix-Trench G., Gayther S.A., Pharoah P.D., Laird P.W., Goode E.L., Pearce C.L. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat. Commun. 2013, 4:1628.
71. Small K.S., Hedman A.K., Grundberg E., Nica A.C., Thorleifsson G., Kong A., Thorsteindottir U., Shin S.Y., Richards H.B., GIANT Consortium, MAGIC Investigators, DIAGRAM Consortium, Soranzo N., Ahmadi K.R., Lindgren C.M., Stefansson K., Dermitzakis E.T., Deloukas P., Spector T.D., McCarthy M.I., MuTHER Consortium Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes. Nat. Genet. 2011, 43:561-564.
72. Smemo S., Tena J.J., Kim K.H., Gamazon E.R., Sakabe N.J., Gómez-Marín C., Aneas I., Credidio F.L., Sobreira D.R., Wasserman N.F., Lee J.H., Puviindran V., Tam D., Shen M., Son J.E., Vakili N.A., Sung H.K., Naranjo S., Acemel R.D., Manzanares M., Nagy A., Cox N.J., Hui C.C., Gomez-Skarmeta J.L., Nóbrega M.A. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 2014, 507:371-375.
73. Sotelo J., Esposito D., Duhagon M.A., Banfield K., Mehalko J., Liao H., Stephens R.M., Harris T.J., Munroe D.J., Wu X. Long-range enhancers on 8q24 regulate c-Myc. Proc. Natl. Acad. Sci. USA 2010, 107:3001-3005.
74. Syddall C.M., Reynard L.N., Young D.A., Loughlin J. The identification of trans-acting factors that regulate the expression of GDF5 via the osteoarthritis susceptibility SNP rs143383. PLoS Genet. 2013, 9:e1003557.
75. Szymanski M., Wang R., Bassett S.S., Avramopoulos D. Alzheimer's risk variants in the clusterin gene are associated with alternative splicing. Transl. Psychiatry 2011, 1:e18.
76. Quigley D., Balmain A. Systems genetics analysis of cancer susceptibility: from mouse models to humans. Nat. Rev. Genet. 2009, 10:651-657.
77. The CARDIoGRAMplusC4D Consortium Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 2013, 45:25-33.
78. Thomas-Chollier M., Hufton A., Heinig M., O'Keeffe S., Masri N.E., Roider H.G., Manke T., Vingron M. Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs. Nat. Protoc. 2011, 6:1860-1869.
79. Thomson D.W., Bracken C.P., Goodall G.J. Experimental strategies for microRNA target identification. Nucleic Acids Res. 2011, 39:6845-6853.
80. Tuupanen S., Turunen M., Lehtonen R., Hallikas O., Vanharanta S., Kivioja T., Björklund M., Wei G., Yan J., Niittymäki I., Mecklin J.P., Järvinen H., Ristimäki A., Di-Bernardo M., East P., Carvajal-Carmona L., Houlston R.S., Tomlinson I., Palin K., Ukkonen E., Karhu A., Taipale J., Aaltonen L.A. The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat. Genet. 2009, 41:885-890.
81. Verlaan D.J., Berlivet S., Hunninghake G.M., Madore A.M., Larivière M., Moussette S., Grundberg E., Kwan T., Ouimet M., Ge B., Hoberman R., Swiatek M., Dias J., Lam K.C., Koka V., Harmsen E., Soto-Quiros M., Avila L., Celedón J.C., Weiss S.T., Dewar K., Sinnett D., Laprise C., Raby B.A., Pastinen T., Naumova A.K. Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am. J. Hum. Genet. 2009, 85:377-393.
82. Visser M., Kayser M., Palstra R.J. HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter. Genome Res. 2012, 22:446-455.
83. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., Zeggini E., Huth C., Aulchenko Y.S., Thorleifsson G., McCulloch L.J., Ferreira T., Grallert H., Amin N., Wu G., Willer C.J., Raychaudhuri S., McCarroll S.A., Langenberg C., Hofmann O.M., Dupuis J., Qi L., Segrè A.V., van Hoek M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett A.J., Blagieva R., Boerwinkle E., Bonnycastle L.L., Bengtsson Boström K., Bravenboer B., Bumpstead S., Burtt N.P., Charpentier G., Chines P.S., Cornelis M., Couper D.J., Crawford G., Doney A.S., Elliott K.S., Elliott A.L., Erdos M.R., Fox C.S., Franklin C.S., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves C.J., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson A.U., Johnson P.R., Jørgensen T., Kao W.H., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren C.M., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken M.A., Narisu N., Nilsson P., Owen K.R., Payne F., Perry J.R., Petersen A.K., Platou C., Proença C., Prokopenko I., Rathman W., Rayne N.W., Robertson N.R., Rocheleau G., Roden M., Sampson M.J., Saxena R., Shields B.M., Shrader P., Sigurdsson G., Sparsø T., Strassburger K., Stringham H.M., Sun Q., Swift A.J., Thorand B., Tichet J., Tuomi T., van Dam R.M., van Haeften T.W., van Herpt T., van Vliet-Ostaptchouk J.V., Walters G.B., Weedon M.N., Wijmenga C., Witteman J., Bergman R.N., Cauchi S., Collins F.S., Gloyn A.L., Gyllensten U., Hansen T., Hide W.A., Hitman G.A., Hofman A., Hunter D.J., Hveem K., Laakso M., Mohlke K.L., Morris A.D., Palmer C.N., Pramstaller P.P., Rudan I., Sijbrands E., Stein L.D., Tuomilehto J., Uitterlinden A., Walker M., Wareham N.J., Watanabe R.M., Abecasis G.R., Boehm B.O., Campbell H., Daly M.J., Hattersley A.T., Hu F.B., Meigs J.B., Pankow J.S., Pedersen O., Wichmann H.E., Barroso I., Florez J.C., Frayling T.M., Groop L., Sladek R., Thorsteinsdottir U., Wilson J.F., Illig T., Froguel P., van Duijn C.M., Stefansson K., Altshuler D., Boehnke M., McCarthy M.I., MAGIC investigators, GIANT Consortium Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
84. Wasserman N.F., Aneas I., Nobrega M.A. An 8q24 gene desert variant associated with prostate cancer risk confers differential invivo activity to a MYC enhancer. Genome Res. 2010, 20:1191-1197.
85. Welter D., MacArthur J., Morales J., Burdett T., Hall P., Junkins H., Klemm A., Flicek P., Manolio T., Hindorff L., Parkinson H. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014, 42:D1001-D1006.
86. Wright J.B., Brown S.J., Cole M.D. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol. Cell Biol. 2010, 30:1411-1420.
87. Xu Z., Taylor J.A. SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res. 2009, 37:W600-W605.
88. Yu C.Y., Theusch E., Lo K., Mangravite L.M., Naidoo D., Kutilova M., Medina M.W. HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism. Hum. Mol. Genet. 2014, 23:319-332.
89. Zhang B., Gaiteri C., Bodea L.G., Wang Z., McElwee J., Podtelezhnikov A.A., Zhang C., Xie T., Tran L., Dobrin R., Fluder E., Clurman B., Melquist S., Narayanan M., Suver C., Shah H., Mahajan M., Gillis T., Mysore J., MacDonald M.E., Lamb J.R., Bennett D.A., Molony C., Stone D.J., Gudnason V., Myers A.J., Schadt E.E., Neumann H., Zhu J., Emilsson V. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease. Cell 2013, 153:707-720.
90. Zhang X., Cowper-Sal lari R., Bailey S.D., Moore J.H., Lupien M. Integrative functional genomics identifies an enhancer looping to the SOX9 gene disrupted by the 17q24.3 prostate cancer risk locus. Genome Res. 2012, 22:1437-1446.
91. Zhou B., Wei F.Y., Kanai N., Fujimura A., Kaitsuka T., Tomizawa K. Identification of a splicing variant that regulates type 2 diabetes risk factor CDKAL1 level by a coding-independent mechanism in human. Hum. Mol. Genet. 2014, 23:4639-4650.
92. Zhou X., Baron R.M., Hardin M., Cho M.H., Zielinski J., Hawrylkiewicz I., Sliwinski P., Hersh C.P., Mancini J.D., Lu K., Thibault D., Donahue A.L., Klanderman B.J., Rosner B., Raby B.A., Lu Q., Geldart A.M., Layne M.D., Perrella M.A., Weiss S.T., Choi A.M., Silverman E.K. Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP. Hum. Mol. Genet. 2012, 21:1325-1335.